You are here

Article info

Article menu

Download PDFPDF

Commentary
Immunotherapy resistance: the answers lie ahead – not in front – of us

Authors

  • Miles C. Andrews Department of Surgical OncologyThe University of Texas MD Anderson Cancer Center 1400 Pressler Street, Unit Number 1484 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Jennifer A. Wargo Department of Surgical OncologyThe University of Texas MD Anderson Cancer Center 1400 Pressler Street, Unit Number 1484 77030 Houston TX USA Department of Genomic MedicineThe University of Texas MD Anderson Cancer Center 1400 Pressler Street, Unit Number 1484 77030 Houston TX USA PubMed articlesGoogle scholar articles
  1. ↵a MCAndrews{at}mdanderson.org
  2. ↵b JWargo{at}mdanderson.org
View Full Text

Citation

Andrews MC, Wargo JA
Immunotherapy resistance: the answers lie ahead – not in front – of us
Journal for ImmunoTherapy of Cancer 2017;5:10. doi: 10.1186/s40425-017-0212-y

Publication history

  • Received December 2, 2016
  • Accepted January 20, 2017
  • First published February 21, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.